Search results
Biotech Stock Roundup: BIIB, Eisai's Drug Update, NVAX Gains on Deal Amendment
Zacks via Yahoo Finance· 10 months agoIt was a busy week for the biotech sector, with many important regulatory and pipeline updates....
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
Zacks via Yahoo Finance· 1 year agoBiogen Inc. BIIB and partner Eisai announced that the latter submitted a marketing authorization...
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Benzinga via Yahoo Finance· 1 year agoThe FDA has accepted Eisai Co Ltd (OTC: ESALY) and Biogen Inc's (NASDAQ: BIIB) supplemental...
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Benzinga via Yahoo Finance· 2 years agoEisai Co Ltd (OTC: ESALY) has completed the rolling submission of the FDA marketing application...
Merck (MRK), Eisai Combo Therapy Fail Two Lung Cancer Studies
Zacks via Yahoo Finance· 7 months agoData from both late-stage studies evaluating Merck's (MRK) Keytruda and Eisai's Lenvima combination...
Merck (MRK), Eisai to End Keytruda-Lenvima Combo Cancer Study
Zacks via Yahoo Finance· 8 months agoWith the phase III LEAP-010 study failing to show an overall survival benefit for patients with...
Biotech Stock Roundup: KDNY Up on NVS Buyout, BIIB & Eisai's AD Drug Update & More
Zacks via Yahoo Finance· 11 months agoIt was a busy week for the biotech sector. Key regulatory and pipeline updates from bigwigs like...
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Zacks via Yahoo Finance· 1 month agoPer Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to...
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance· 4 months agoHow much a stock's price changes over time is a significant driver for most investors. Not only can...
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Benzinga via Yahoo Finance· 1 year agoEisai Co Ltd (OTC: ESALY) and Biogen Inc (NASDAQ: BIIB) announced that three additional detailed...